KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.70 $3.18 Thursday, 25th Apr 2024 GLYC stock ended at $1.71. This is 7.82% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.81% from a day low at $1.70 to a day high of $1.81.
90 days $1.70 $3.50
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Jan 08, 2024 $2.78 $2.91 $2.78 $2.90 142 906
Jan 05, 2024 $2.96 $2.96 $2.67 $2.80 381 775
Jan 04, 2024 $3.10 $3.25 $2.75 $3.00 702 372
Jan 03, 2024 $2.80 $3.05 $2.67 $3.03 633 725
Jan 02, 2024 $2.32 $2.72 $2.20 $2.72 346 997
Dec 29, 2023 $2.48 $2.51 $2.33 $2.36 141 764
Dec 28, 2023 $2.49 $2.56 $2.38 $2.51 296 450
Dec 27, 2023 $2.52 $2.65 $2.43 $2.49 311 157
Dec 26, 2023 $2.56 $2.76 $2.42 $2.52 542 151
Dec 22, 2023 $2.22 $2.57 $2.22 $2.54 1 120 636
Dec 21, 2023 $2.12 $2.16 $2.01 $2.13 264 219
Dec 20, 2023 $2.11 $2.17 $2.00 $2.05 274 090
Dec 19, 2023 $2.00 $2.17 $1.97 $2.13 411 538
Dec 18, 2023 $2.03 $2.04 $1.92 $1.97 318 011
Dec 15, 2023 $2.02 $2.14 $1.92 $1.98 359 172
Dec 14, 2023 $1.90 $2.00 $1.75 $2.00 320 147
Dec 13, 2023 $1.75 $1.93 $1.72 $1.87 364 110
Dec 12, 2023 $1.64 $1.80 $1.59 $1.76 279 864
Dec 11, 2023 $1.65 $1.68 $1.59 $1.62 92 284
Dec 08, 2023 $1.59 $1.61 $1.52 $1.61 39 852
Dec 07, 2023 $1.57 $1.64 $1.56 $1.60 37 487
Dec 06, 2023 $1.64 $1.64 $1.55 $1.57 62 366
Dec 05, 2023 $1.61 $1.68 $1.55 $1.64 80 521
Dec 04, 2023 $1.73 $1.74 $1.51 $1.61 281 239
Dec 01, 2023 $1.63 $1.74 $1.60 $1.72 112 810
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT